GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » Institutional Ownership

Incannex Healthcare (STU:IQI) Institutional Ownership : 8.62% (As of May. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Incannex Healthcare Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Incannex Healthcare's institutional ownership is 8.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Incannex Healthcare's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Incannex Healthcare's Float Percentage Of Total Shares Outstanding is 82.15%.


Incannex Healthcare Institutional Ownership Historical Data

The historical data trend for Incannex Healthcare's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare Institutional Ownership Chart

Incannex Healthcare Historical Data

The historical data trend for Incannex Healthcare can be seen below:

2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31
Institutional Ownership 9.51 9.21 7.79 7.90 8.36 9.08 9.09 9.89 8.72 8.62

Incannex Healthcare Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Incannex Healthcare (STU:IQI) Business Description

Traded in Other Exchanges
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.